In the first of a planned series, PharmaBrands will bring together stakeholders from across the ecosystem to explore how rare disease teams can deliver more relevant, personalized engagement across increasingly complex patient and stakeholder journeys in 2026.
Please note: This event is for professionals employed by pharma, biotech, medtech, healthcare, or advocacy, who are working to improve outcomes in rare disease.
Special thanks to the event partner:
In Canada, the rare disease journey has too often been marked by uncertainty and delay, but it is being transformed by more accessible insights, faster action, and renewed hope for every patient. I will share a vision on what the future of Rare Disease care could look like.
.png)
Case study on how AI is transforming patient identification and engagement in Canada, and what that means for more timely, targeted rare disease support.
Learn about the challenges of mis- and disinformation in rare disease, and what industry can do to build trust and improve the quality of information patients and HCPs receive.
Hear from leaders on how rare disease support must evolve to become more useful, connected and responsive to real patient and HCP needs in the age of AI and connected health.
This event is for professionals employed by pharma, biotech, medtech, healthcare providers, and advocacy who are working to improve outcomes in rare disease in Canada.
Enjoy stunning views across downtown Toronto from the ChangeMakers Health office.
